After the adult vaccine trials of 18 and up, a drug regulators had a choice in terms of what kind of evidence they need to move down to younger ages. And that the choice they went with was immuno bridging. Immuno bridging means is that we're no longer going to ask the manufacturer to prove that you reduce symptomatic sars cove to. 4 years old has a lower risk than a triple vaccinated forty year old. The potential upside olo, yes, the risk of coven having a severe reaction to coved is ergetting it is lower,. In fact, it's so low that a four-year-old has a lowerrisk than a triple vaccinating 40
When it comes to the COVID-19 vaccination, is the risk of myocarditis greater than the benefit to a healthy male teen? Is natural immunity really better than vaccination--and were we right to mask the kids? Dr. Vinay Prasad of the University of California San Francisco talks with EconTalk host Russ Roberts about what we learned and didn't learn from COVID so far and how we should handle a pandemic going forward.